Symbol | Exchange | Currency |
|---|
Investing.com - Valneva SE reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Valneva SE announced earnings...
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Oil & Gas, Consumer Goods and Telecoms sectors led shares higher. At the close in NYSE, the Dow...
Stocks appear to be pausing as rates start to rise. Before the U.S. markets opened, short-term U.S. Treasury yields were rising. The five-year yields rose to their highest levels...
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2. The company also develops VLA15, a vaccine candidate that has completed Phase II clinical trial against Borrelia; and VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is headquartered in Saint-Herblain, France.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Strong Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 138.00 | 140.32 | 136.25 | -1.45 | -1.04% | 6.90M | NASDAQ | |||
| 180.83 | 186.38 | 178.75 | -2.09 | -1.14% | 83.06M | NASDAQ | |||
| 141.17 | 144.81 | 140.35 | -3.05 | -2.11% | 83.46M | NASDAQ | |||
| 109.46 | 110.94 | 108.54 | +0.68 | +0.63% | 23.36M | NASDAQ | |||
| 74.43 | 74.83 | 74.00 | +0.77 | +1.05% | 412.08K | NYSE | |||
| 62.48 | 62.57 | 61.98 | -0.22 | -0.35% | 10.96M | NYSE | |||
| 92.42 | 94.41 | 91.44 | -1.53 | -1.63% | 65.17M | NASDAQ | |||
| 379.71 | 385.33 | 377.43 | -5.93 | -1.54% | 1.68M | NASDAQ | |||
| 143.30 | 145.82 | 142.13 | -1.95 | -1.34% | 3.02M | NASDAQ | |||
| 37.00 | 37.15 | 36.72 | +0.14 | +0.38% | 26.95M | NYSE | |||
| 34.81 | 35.55 | 34.49 | +0.02 | +0.06% | 560.07K | NASDAQ | |||
| 9.04 | 9.20 | 8.93 | +0.30 | +3.43% | 4.85M | NYSE | |||
| 96.71 | 98.17 | 96.71 | -0.90 | -0.92% | 215.44K | NYSE | |||
| 246.42 | 249.32 | 244.51 | +0.78 | +0.32% | 940.35K | NYSE | |||
| 240.33 | 242.79 | 238.21 | -1.43 | -0.59% | 17.49M | NASDAQ |